摘要
中药配方颗粒因其具有使用方便、快速,便于储存运输,有利于实现中药的标准化等优点,使其行业发展进入了新的阶段。我国药品监管部门加强了配方颗粒的研制、生产和使用相关法规的制定,截至2022年9月,国家已公示200个中药配方颗粒的标准(简称国家标准),这些标准中包括同源异效的配方颗粒,通过对“同源异效”配方颗粒的现象进行分析和讨论,并就同源异效配方颗粒质量标准研究提出建议,为完善配方颗粒的研究提供参考。
Because of its convenient use,rapid use,convenient storage and transportation,and the standardization of traditional Chinese medicine,the development of the industry has entered a new stage.China’s drug regulatory authorities to strengthen the development,production and use of formula granule regulations,as of September 2022,the country has public 200 Chinese medicine formula particles standard(national standard),which include the formula granules with homologous and heterologous effect.Through analyzing and discussing the phenomenon of“homologous and heterologous effect”formula granules,suggestions on the quality standards of homologous and heterologous effect formula granules are put forward to provide reference for improving the research of formula granules.
作者
张文慧
雷燕莉
谢志伟
田佩灵
雷诗懿
刘涛
ZHANG Wen-hui;LEI Yan-li;XIE Zhi-wei;TIAN Pei-ling;LEI Shi-yi;LIU Tao(School of Pharmacy,Chengdu University,Chengdu 610106,China;College of Food and Bioengineering,Chengdu University,Chengdu 610106,China;Engineering Research Center for Anti-Viral Traditional Chinese Medicine of Sichuan Province,Chengdu 610106,China)
出处
《中草药》
CAS
CSCD
北大核心
2023年第7期2319-2326,共8页
Chinese Traditional and Herbal Drugs
基金
四川省2021-2023年高等教育人才培养质量和教学改革项目(JG2021-1106)
四川省科技成果转化示范项目(23ZHSF0218)。
关键词
中药配方颗粒
质量标准
同源异效
差异性研究
国家标准
traditional Chinese medicine formula granules
quality standards
homologous and heterologous effect
difference research
national standard
